EPE Special Opportunities Limited Stock
Equities
ESO
BMG3163K1053
Investment Management & Fund Operators
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
157.5 GBX | 0.00% | +3.62% | -2.17% |
Apr. 02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
Mar. 28 | Earnings Flash (ESO.L) EPE SPECIAL OPPORTUNITIES Reports FY24 Loss GBX-1.33 | MT |
Sales 2023 | -39.36M -49.07M | Sales 2024 | 3.75M 4.68M | Capitalization | 49.3M 61.46M |
---|---|---|---|---|---|
Net income 2023 | -43M -53.61M | Net income 2024 | - 0 | EV / Sales 2023 | -1.34 x |
Net Debt 2023 | 2.48M 3.1M | Net cash position 2024 | 2.02M 2.52M | EV / Sales 2024 | 12.6 x |
P/E ratio 2023 |
-1.2
x | P/E ratio 2024 |
-118
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 40.26% |
1 week | +3.62% | ||
Current month | +6.78% | ||
1 month | -2.17% | ||
3 months | -2.17% | ||
6 months | -11.27% | ||
Current year | -2.17% |
Managers | Title | Age | Since |
---|---|---|---|
Corporate Secretary | 74 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pirouet
BRD | Director/Board Member | 69 | 19-06-30 |
Clive Spears
CHM | Chairman | 70 | - |
Heather Bestwick
BRD | Director/Board Member | - | 17-02-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 157.5 | 0.00% | 0 |
24-04-17 | 157.5 | 0.00% | 10,000 |
24-04-16 | 157.5 | +0.64% | 0 |
24-04-15 | 156.5 | +1.95% | 0 |
24-04-12 | 153.5 | 0.00% | 5,994 |
Delayed Quote London S.E., April 18, 2024 at 02:59 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-2.17% | 58.58M | |
+2.51% | 35.42B | |
+7.96% | 33.18B | |
+5.44% | 5.45B | |
-1.98% | 3.02B | |
+10.13% | 2.85B | |
+12.38% | 2.66B | |
+4.52% | 1.24B | |
-6.54% | 1.02B | |
+0.85% | 853M |
- Stock Market
- Equities
- ESO Stock